RP Bio Inc. (KOSDAQ:314140)

RP Bio Statistics

Total Valuation

RP Bio has a market cap or net worth of KRW 46.97 billion. The enterprise value is 46.49 billion.

Market Cap	46.97B
Enterprise Value	46.49B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	Dec 29, 2025

Share Statistics

RP Bio has 8.67 million shares outstanding. The number of shares has increased by 0.10% in one year.

Current Share Class	8.67M
Shares Outstanding	8.67M
Shares Change (YoY)	+0.10%
Shares Change (QoQ)	+0.16%
Owned by Insiders (%)	61.75%
Owned by Institutions (%)	n/a
Float	3.31M

Valuation Ratios

The trailing PE ratio is 8.37.

PE Ratio	8.37
Forward PE	n/a
PS Ratio	0.34
PB Ratio	0.43
P/TBV Ratio	0.43
P/FCF Ratio	3.71
P/OCF Ratio	2.85
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.87, with an EV/FCF ratio of 3.68.

EV / Earnings	8.30
EV / Sales	0.34
EV / EBITDA	3.87
EV / EBIT	8.15
EV / FCF	3.68

Financial Position

The company has a current ratio of 1.34, with a Debt / Equity ratio of 0.21.

Current Ratio	1.34
Quick Ratio	0.80
Debt / Equity	0.21
Debt / EBITDA	1.88
Debt / FCF	1.78
Interest Coverage	8.09

Financial Efficiency

Return on equity (ROE) is 5.26% and return on invested capital (ROIC) is 5.16%.

Return on Equity (ROE)	5.26%
Return on Assets (ROA)	2.17%
Return on Invested Capital (ROIC)	5.16%
Return on Capital Employed (ROCE)	4.97%
Weighted Average Cost of Capital (WACC)	5.37%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.84
Inventory Turnover	4.87

Taxes

Income Tax	-42.03M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.54% in the last 52 weeks. The beta is 0.46, so RP Bio's price volatility has been lower than the market average.

Beta (5Y)	0.46
52-Week Price Change	-1.54%
50-Day Moving Average	6,157.60
200-Day Moving Average	6,731.60
Relative Strength Index (RSI)	38.49
Average Volume (20 Days)	17,426

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, RP Bio had revenue of KRW 137.35 billion and earned 5.60 billion in profits. Earnings per share was 647.53.

Revenue	137.35B
Gross Profit	14.35B
Operating Income	5.70B
Pretax Income	5.56B
Net Income	5.60B
EBITDA	12.01B
EBIT	5.70B
Earnings Per Share (EPS)	647.53

Balance Sheet

The company has 23.04 billion in cash and 22.56 billion in debt, with a net cash position of 478.15 million or 55.17 per share.

Cash & Cash Equivalents	23.04B
Total Debt	22.56B
Net Cash	478.15M
Net Cash Per Share	55.17
Equity (Book Value)	109.32B
Book Value Per Share	12,618.14
Working Capital	16.84B

Cash Flow

In the last 12 months, operating cash flow was 16.46 billion and capital expenditures -3.82 billion, giving a free cash flow of 12.65 billion.

Operating Cash Flow	16.46B
Capital Expenditures	-3.82B
Depreciation & Amortization	6.31B
Net Borrowing	-5.65B
Free Cash Flow	12.65B
FCF Per Share	1,459.12

Margins

Gross margin is 10.44%, with operating and profit margins of 4.15% and 4.08%.

Gross Margin	10.44%
Operating Margin	4.15%
Pretax Margin	4.05%
Profit Margin	4.08%
EBITDA Margin	8.75%
EBIT Margin	4.15%
FCF Margin	9.21%

Dividends & Yields

This stock pays an annual dividend of 50.00, which amounts to a dividend yield of 0.89%.

Dividend Per Share	50.00
Dividend Yield	0.89%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.10%
Shareholder Yield	0.80%
Earnings Yield	11.93%
FCF Yield	26.92%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

RP Bio has an Altman Z-Score of 2.02 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.02
Piotroski F-Score	7